Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Hoffmann

Showing results (261-270 of 312) with videos related to

Pageof 32
Sort By:
Cellular & Molecular Immunology|January 7, 2022
MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccinationYeonsu Kim, Xiaoyan Zheng, Kathrin Eschke, et al.
Biorxiv : the Preprint Server for Biology|August 15, 2020
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activityMarkus Hoffmann, Heike Hofmann-Winkler, Joan C Smith, et al.
European Journal of Immunology|March 5, 2022
Neutralizing antibody responses 300 days after SARS-CoV-2 infection and induction of high antibody titers after vaccinationDoris Urlaub, Natalie Wolfsdorff, Jan-Erik Hoffmann, et al.
Antioxidants & Redox Signaling|May 3, 2014
Reactive oxygen species deficiency induces autoimmunity with type 1 interferon signatureTiina Kelkka, Deborah Kienhöfer, Markus Hoffmann, et al.
Nucleic Acids Research|October 30, 2014
Resveratrol post-transcriptionally regulates pro-inflammatory gene expression via regulation of KSRP RNA binding activityFranziska Bollmann, Julia Art, Jenny Henke, et al.
Kidney International|October 7, 2021
Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal diseaseUlrik Stervbo, Arturo Blazquez-Navarro, Elena Vidal Blanco, et al.
Cell|January 9, 2024
SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiencyLu Zhang, Amy Kempf, Inga Nehlmeier, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2022
A single-dose MCMV-based vaccine elicits long-lasting immune protection in mice against distinct SARS-CoV-2 variantsKristin Metzdorf, Henning Jacobsen, Yeonsu Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2016
Nanoparticles size-dependently initiate self-limiting NETosis-driven inflammationLuis E Muñoz, Rostyslav Bilyy, Mona H C Biermann, et al.
Frontiers in Immunology|August 9, 2024
A single-dose MCMV-based vaccine elicits long-lasting immune protection in mice against distinct SARS-CoV-2 variantsKristin Metzdorf, Henning Jacobsen, Yeonsu Kim, et al.
Pageof 32

Showing results (261-270 of 312) with videos related to

Sort By:
Pageof 32
Cellular & Molecular Immunology|January 7, 2022
MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccinationYeonsu Kim, Xiaoyan Zheng, Kathrin Eschke, et al.
Biorxiv : the Preprint Server for Biology|August 15, 2020
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activityMarkus Hoffmann, Heike Hofmann-Winkler, Joan C Smith, et al.
European Journal of Immunology|March 5, 2022
Neutralizing antibody responses 300 days after SARS-CoV-2 infection and induction of high antibody titers after vaccinationDoris Urlaub, Natalie Wolfsdorff, Jan-Erik Hoffmann, et al.
Antioxidants & Redox Signaling|May 3, 2014
Reactive oxygen species deficiency induces autoimmunity with type 1 interferon signatureTiina Kelkka, Deborah Kienhöfer, Markus Hoffmann, et al.
Nucleic Acids Research|October 30, 2014
Resveratrol post-transcriptionally regulates pro-inflammatory gene expression via regulation of KSRP RNA binding activityFranziska Bollmann, Julia Art, Jenny Henke, et al.
Kidney International|October 7, 2021
Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal diseaseUlrik Stervbo, Arturo Blazquez-Navarro, Elena Vidal Blanco, et al.
Cell|January 9, 2024
SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiencyLu Zhang, Amy Kempf, Inga Nehlmeier, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2022
A single-dose MCMV-based vaccine elicits long-lasting immune protection in mice against distinct SARS-CoV-2 variantsKristin Metzdorf, Henning Jacobsen, Yeonsu Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2016
Nanoparticles size-dependently initiate self-limiting NETosis-driven inflammationLuis E Muñoz, Rostyslav Bilyy, Mona H C Biermann, et al.
Frontiers in Immunology|August 9, 2024
A single-dose MCMV-based vaccine elicits long-lasting immune protection in mice against distinct SARS-CoV-2 variantsKristin Metzdorf, Henning Jacobsen, Yeonsu Kim, et al.
Pageof 32